Potential use of recombinant human hematopoietic growth factors in pediatrics Journal Article


Author: Gillio, A. P.
Article Title: Potential use of recombinant human hematopoietic growth factors in pediatrics
Abstract: Over the last decade, the most significant advance in hematology has been the isolation, cloning, and large-scale production of hematopoietic growth factors. In vivo, these factors stimulate bone marrow progenitor cells, resulting in increased production of mature peripheral blood cells. Most of the phase III trials of these factors have involved adult patients, although a number of pediatric phase I/II trials have been reported. To date, these trials have shown that the toxicity and efficacy of these agents in children and adults are similar. Therefore, despite the paucity of pediatric data and lack of US Food and Drug Administration approval for their use in children, these factors are being used extensively in pediatrics, especially at tertiary care centers. In this article, the clinical trials of erythropoietin, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and interleukin-3 are reviewed.
Keywords: child; neutropenia; review; drug efficacy; phase 2 clinical trial; erythropoietin; granulocyte macrophage colony stimulating factor; kidney failure; fever; myelodysplastic syndrome; neutrophil; headache; bone marrow cell; leukocyte count; phase 1 clinical trial; cell stimulation; bone marrow transplantation; erythrocyte transfusion; influenza; granulocyte colony stimulating factor; intravenous drug administration; hemopoietic growth factor; aplastic anemia; interleukin 3; subcutaneous drug administration; human
Journal Title: Current Opinion in Pediatrics
Volume: 4
Issue: 2
ISSN: 1040-8703
Publisher: Lippincott Williams & Wilkins  
Date Published: 1992-04-01
Start Page: 319
End Page: 326
Language: English
DOI: 10.1097/00008480-199204000-00020
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 30 July 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alfred P. Gillio
    89 Gillio